Jasmine Haddad


Haddad, Jasmine

Jasmine Haddad's practice focuses on all aspects of corporate law. She represents public and private companies in a variety of industries, including technology, life sciences and financial services.

While in law school, Ms. Haddad worked as a summer law clerk at a Boston firm, where she assisted with long-term care planning with a focus on asset protection. Ms. Haddad also worked as a research assistant for Professor Linda C. McClain. In that role, Ms. Haddad researched the changing legal landscape of same-sex marriage following the Windsor decision.

Ms. Haddad was a summer associate at WilmerHale in 2015, where she focused on corporate matters. Previously, Ms. Haddad worked as a consumer advocate intern at the Connecticut Office of the Attorney General, and as a fund development coordinator for a local nonprofit organization.

Publications & News


January 30, 2018

WilmerHale Represents Ocular Therapeutix™ in Public Offering of Common Stock

Ocular Therapeutix™, Inc. announced the closing of its underwritten public offering of 7,475,000 shares of its common stock at a public offering price of $5.00 per share.

November 29, 2017

WilmerHale Represents Akamai in Acquisition of Nominum

Akamai Technologies, Inc. announced the company completed its acquisition of Nominum, a provider of DNS-based security solutions supporting many of the world's leading carriers.

November 6, 2017

WilmerHale Represents 1366 Technologies in $9M Series D Funding

Developer of manufacturing solutions for silicon cell manufacturers, 1366 Technologies, has raised $9 million in Series D funding from strategic partners and return investors.

July 24, 2017

WilmerHale Reps Emergent BioSolutions in $96M Acquisition of GlaxoSmithKline Anthrax Drug

Emergent BioSolutions announced it would acquire a drug for treating inhaled anthrax from pharmaceutical giant GlaxoSmithKline in an all-cash deal worth up to $96 million.

April 28, 2017

2017 M&A Report

Our 2017 M&A Report provides a detailed global M&A market review and outlook. Other highlights include takeover defenses for public companies; key lessons for buyers and sellers considering earnouts; recent developments in merger control regulation; common interest privilege protection among deal parties; special considerations in California M&A deals; acquisition financial statement requirements for IPO companies; a comparison of deal terms in public and private acquisitions; and key terms and issues in sales of VC-backed companies.


Skip Navigation Links.


JD, summa cum laude, Boston University School of Law, 2016, Notes Editor, Boston University Law Review, William L. & Lillian Berger Achievement Prize, Edward F. Hennessey Distinguished Scholar

BA, Political Science and Sociology, magna cum laude, Mount Holyoke College, 2012

Bar Admissions



Skip Navigation Links.